GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q2 2024
Top Holdings48 positions
TENET HEALTHCARE CORPORATION | 4.7M | $620.7M | 12.2% | $34.63 | +284.17% | 23 qtrssince 2018-Q4 | Decreased 0 |
CVS Health Corp | 9.2M | $541.1M | 10.7% | $57.39 | -5.70% | 3 qtrssince 2023-Q4 | Increased 99 |
Halfmoon Parent Inc | 1.3M | $427.7M | 8.4% | $230.05 | +37.35% | 23 qtrssince 2018-Q4 | Decreased 0 |
Global Payments Inc | 3.1M | $301.5M | 5.9% | $132.19 | -28.74% | 15 qtrssince 2020-Q4 | Increased 77 |
Corteva Inc | 5.1M | $273.6M | 5.4% | $50.77 | +4.56% | 19 qtrssince 2019-Q4 | Decreased 0 |
iShares Russell 2000 ETF | 1.2M | $233.7M | 4.6% | — | — | — | Decreased — |
ALIGHT INC | 30.9M | $227.7M | 4.5% | $8.42 | -16.23% | 8 qtrssince 2022-Q3 | Increased 62 |
Universal Health Services Inc | 1.2M | $219M | 4.3% | $147.97 | +24.23% | 7 qtrssince 2022-Q4 | Decreased 0 |
iShares Transportation Average ETF | 6.3M | $171.6M | 3.4% | $20.99 | +25.97% | 22 qtrssince 2019-Q1 | Decreased 0 |
DXC Technology Co | 8.7M | $166.2M | 3.3% | $34.02 | -43.89% | 23 qtrssince 2018-Q4 | Decreased 0 |
McKesson Corp | 265,717 | $155.2M | 3.1% | $144.46 | +301.63% | 23 qtrssince 2018-Q4 | Decreased 0 |
Teva Pharmaceutical Industries | 9.2M | $148.8M | 2.9% | $13.85 | +17.29% | 3 qtrssince 2023-Q4 | Increased 64 |
Clarivate Analytics PLC | 25.7M | $146M | 2.9% | $9.12 | -37.62% | 9 qtrssince 2022-Q2 | Increased 55 |
US Foods Holding Corp | 2.5M | $132.2M | 2.6% | $41.72 | +26.98% | 11 qtrssince 2021-Q4 | Decreased 0 |
SPDR S&P 500 ETF Trust | 232,900 | $126.7M | 2.5% | — | — | — | Decreased — |
Centene Corp | 1.4M | $94.9M | 1.9% | $66.30 | 0.00% | 1 qtr | New 69 |
MYRIAD GENETICS INC | 3.7M | $91.7M | 1.8% | $18.94 | +29.13% | 20 qtrssince 2019-Q3 | Decreased 0 |
Uber Technologies Inc | 1.2M | $87M | 1.7% | $43.56 | +66.86% | 13 qtrssince 2021-Q2 | Increased 51 |
Expedia Inc | 599,438 | $75.5M | 1.5% | $96.43 | +29.61% | 8 qtrssince 2022-Q3 | Decreased 0 |
Knight-Swift Transportation Ho | 1.5M | $72.6M | 1.4% | $50.55 | -3.35% | 6 qtrssince 2023-Q1 | Increased 52 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $5.1B across 48 positions as of Q2 2024. Top holdings: THC (12.2%), CVS (10.7%), CI (8.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 9 new positions, 6 exits, 13 increased. Top move: CVS (INCREASED, conviction 99). Portfolio: $5.1B across 48 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR